Neuroendocrine tumor (NET) treatment in Istanbul, Turkey
Neuroendocrine tumors (NETs) form from neuroendocrine cells, most often in the gastrointestinal tract — including the pancreas — and lungs. Surgery is the main treatment for localized tumours, while somatostatin analogs such as octreotide and lanreotide control hormone symptoms and slow growth. For somatostatin-receptor-positive tumours, PRRT with lutetium Lu 177 dotatate delivers radiation to the tumour, and targeted drugs such as everolimus or sunitinib are used for pancreatic NETs. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
Overview of the digestive system — the esophagus, stomach, small and large intestine, and the accessory organs (liver, gallbladder, pancreas).
SEER Training Modules, U.S. National Cancer Institute — public domain (opens in a new tab) ↗What neuroendocrine tumors are
The U.S. National Cancer Institute describes neuroendocrine tumors (NETs) as tumours that form from neuroendocrine cells — cells that both make hormones and behave like nerve cells. They most often arise in the gastrointestinal tract, including the pancreas (pancreatic NETs), and in the lungs. NETs range from slow-growing, well-differentiated tumours to aggressive, poorly-differentiated neuroendocrine carcinoma, and the grade of the tumour strongly shapes how it is treated.
Some NETs are “functional” and secrete hormones that cause symptoms — the NCI describes carcinoid syndrome, with flushing and diarrhea, as one example. Staging often uses a Gallium-68 DOTATATE PET scan, which shows whether the tumour carries somatostatin receptors and helps decide whether receptor-targeted therapy will work. Because early NETs can cause vague symptoms or none at all, they are sometimes found at a more advanced stage. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for neuroendocrine tumors, and an honest note on each:
- Surgery. The main treatment for localized NETs — removing the tumour, and sometimes nearby lymph nodes, offers the best chance of control when the disease has not spread. Whether an operation is possible depends on the tumour’s size, location and grade.
- Somatostatin analogs. Drugs such as octreotide and lanreotide both control the symptoms of hormone-secreting (functional) tumours and can slow tumour growth. They are given as injections over time, so cost scales with the length of treatment.
- PRRT (lutetium Lu 177 dotatate). Peptide receptor radionuclide therapy delivers radiation directly to somatostatin-receptor-positive tumours. A Gallium-68 DOTATATE PET scan is done first to confirm the receptors are present; whether PRRT applies depends on that imaging and the tumour grade.
- Targeted therapy and chemotherapy. For pancreatic NETs, targeted drugs such as everolimus and sunitinib may be used, while chemotherapy is more often reserved for higher-grade, faster-growing tumours. Which applies is decided by your tumour grade and testing, not a template.
See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single neuroendocrine-tumor price, because the cost is driven by whether surgery is possible, how many somatostatin-analog injections are given over time, whether PRRT with lutetium Lu 177is used, whether targeted drugs such as everolimus or sunitinib are added, and how many chemotherapy cycles a higher-grade tumour needs — the radionuclide and targeted therapies are priced per treatment and can dominate the total. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling surgeons or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose surgical, nuclear-medicine and medical-oncology subspecialties fit your diagnosis — PRRT, for instance, needs a nuclear-medicine unit — and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis within the broader cancer treatment in Istanbul pillar. If you want your own reports read first, a free second opinion organizes and verifies your pathology and imaging into a plain-language case file in your language before you decide whether to travel.
Related cancers
Check everything here — us included
Common questions
Can I get neuroendocrine tumor (NET) treatment in Turkey?
Yes. Istanbul hospitals provide the full NET pathway the U.S. National Cancer Institute describes — surgery to remove localized tumours, somatostatin analogs such as octreotide or lanreotide to control hormone symptoms and slow growth, peptide receptor radionuclide therapy (PRRT) with lutetium Lu 177 dotatate for somatostatin-receptor-positive tumours, targeted drugs such as everolimus or sunitinib for pancreatic NETs, and chemotherapy for higher-grade disease. Gallium-68 DOTATATE PET imaging helps stage the tumour. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. The honest first step is a free case review of your pathology and imaging so the plan is understood before you travel.
What is PRRT (lutetium Lu 177 dotatate)?
PRRT stands for peptide receptor radionuclide therapy, a treatment the NCI describes for certain neuroendocrine tumours. Many NETs carry somatostatin receptors on their surface; PRRT links a radioactive isotope such as lutetium Lu 177 to a peptide that binds those receptors, delivering radiation directly to the tumour cells. It is used for somatostatin-receptor-positive tumours, which is why a Gallium-68 DOTATATE PET scan is done first to confirm the receptors are present. Whether PRRT fits your case depends on that imaging, the tumour grade and prior treatments. This is general information, not a treatment recommendation, and a case review will flag whether the receptor imaging has already been done on your reports.
How are functional (hormone-secreting) neuroendocrine tumors managed?
Some NETs are “functional,” meaning they secrete hormones that cause symptoms — the NCI describes carcinoid syndrome, with flushing and diarrhea, as one example. Managing these tumours means treating both the tumour and the hormone effects. Somatostatin analogs such as octreotide and lanreotide are a mainstay because they both control the hormone-driven symptoms and can slow tumour growth. Surgery to remove the tumour, PRRT, targeted therapy and, for higher-grade disease, chemotherapy may all be part of the plan. Which combination fits your case is a decision for a specialist team, and a case review will tell you what your reports do and don't yet establish about the tumour's grade and hormone activity.
How much does neuroendocrine tumor treatment cost in Istanbul?
There is no single figure, because the cost is driven by whether surgery is possible, how many somatostatin-analog injections are given over time, whether PRRT with lutetium Lu 177 is used, whether targeted drugs such as everolimus or sunitinib are added, and how many chemotherapy cycles a higher-grade tumour needs — the radionuclide and targeted therapies are priced per treatment and can dominate the total. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your pathology and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.